Skip to content

Fibromyalgia on the move...! Randomised study on the effect and cost-effectiveness of a multidisciplinary part-time daycare intervenion.

Randomised study on the effect and cost-effectiveness of a multidisciplinary part-time daycare intervention in fibromyalgia patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21959
Enrollment
214
Registered
2005-10-18
Start date
2004-01-23
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia.

Interventions

1. 12-week multidisciplinary part-time day-care intervention
2. 12-week aerobics exercise

Sponsors

azM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Recently diagnosed fibromyalgia; 2. Age 18-65; 3. Be able to read en write Dutch; 4. Physical be able to spend 12 hours a week on therapy; 5. Be able to be present at least 85% of the treatment time; 6. Motivated into all parts of the treatment program.

Exclusion criteria

Exclusion criteria: 1. Involved in any litigation concerning disability income; 2. Serious psychopathology through which a patient is unsuitable to take part in the group treatment; 3. Serious depression (measured by SCL-90); 4. Specific medical diseases for which medical treatment is necessary immediately or through which patients can not take part in the physical therapeutic treatment; 5. Addiction problems; 6. Pregnancy; 7. Complicated home situation/Fibromyalgia is not most important problem; 8. Use of supportive equipment for ambulation.

Design outcomes

Secondary

MeasureTime frame
1. Pain; 2. Anxiety; 3. Self-efficacy; 4. Catastrophying; 5. Fatigue; 6. Disability.

Primary

MeasureTime frame
1. Social participation; 2. Medical consumption; 3. Quality of life.

Contacts

Public ContactM.E.A.L. Kroese

University Hospital Maastricht, BZe VII - Transmurale Zorg, P.O. Box 5800

mkroes@adcc.azm.nl+31 (0)43 3874406

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)